Canada Markets closed

GW Pharmaceuticals plc (GWPH)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
109.37-22.73 (-17.21%)
At close: 4:00PM EDT
Currency in USD

Valuation Measures

Market Cap (intraday) 53.58B
Enterprise Value 32.96B
Trailing P/E N/A
Forward P/E 149.94
PEG Ratio (5 yr expected) 1-0.09
Price/Sales (ttm)8.10
Price/Book (mrq)4.75
Enterprise Value/Revenue 36.70
Enterprise Value/EBITDA 6-67.28

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-20.89%
S&P500 52-Week Change 3N/A
52 Week High 3166.59
52 Week Low 367.98
50-Day Moving Average 3128.95
200-Day Moving Average 3113.66

Share Statistics

Avg Vol (3 month) 3371.75k
Avg Vol (10 day) 3549.79k
Shares Outstanding 531.08M
Float 30.43M
% Held by Insiders 11.12%
% Held by Institutions 183.33%
Shares Short (Jul. 14, 2020) 44.28M
Short Ratio (Jul. 14, 2020) 415.67
Short % of Float (Jul. 14, 2020) 4N/A
Short % of Shares Outstanding (Jul. 14, 2020) 413.77%
Shares Short (prior month Jun. 14, 2020) 44.5M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Jun. 29, 2020

Profitability

Profit Margin -12.56%
Operating Margin (ttm)-12.22%

Management Effectiveness

Return on Assets (ttm)-3.94%
Return on Equity (ttm)-7.68%

Income Statement

Revenue (ttm)441.98M
Revenue Per Share (ttm)14.20
Quarterly Revenue Growth (yoy)68.40%
Gross Profit (ttm)284.13M
EBITDA -44.05M
Net Income Avi to Common (ttm)-55.5M
Diluted EPS (ttm)-1.78
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)477.56M
Total Cash Per Share (mrq)15.34
Total Debt (mrq)35.14M
Total Debt/Equity (mrq)4.90
Current Ratio (mrq)5.80
Book Value Per Share (mrq)23.02

Cash Flow Statement

Operating Cash Flow (ttm)-67.95M
Levered Free Cash Flow (ttm)-73.79M